Self-Reported Neuropsychiatric Post-COVID-19 Condition and CSF Markers of Neuroinflammation

Overview

Journal JAMA Netw Open

Publisher American Medical Association

Specialty General Medicine

Date 2023 Nov 10

PMID 37948085

Authors

Shelli F Farhadian

Hailey D Reisert

Lindsay McAlpine

Jennifer Chiarella

Priya Kosana

Jennifer Yoon

Serena Spudich

Affiliations

Soon will be listed here.

Citing Articles

CROI 2024: Acute and Post-Acute COVID-19.

Antar A, Peluso M Top Antivir Med. 2025; 32(4):523-541.

PMID: 39746673 PMC: 11361755.

Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations.

Verma A, Lowery S, Lin L, Duraisami E, Abrahante Llorens J, Qiu Q bioRxiv. 2024; .

PMID: 38895239 PMC: 11185538. DOI: 10.1101/2024.06.02.596989.

Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19.

Havdal L, Selvakumar J, Berven L, Stiansen-Sonerud T, Zetterberg H, Blennow K Front Neurol. 2024; 15:1345787.

PMID: 38385031 PMC: 10879600. DOI: 10.3389/fneur.2024.1345787.

References

Heming M, Li X, Rauber S, Mausberg A, Borsch A, Hartlehnert M . Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity. 2020; 54(1):164-175.e6. PMC: 7831653. DOI: 10.1016/j.immuni.2020.12.011. View

Song E, Bartley C, Chow R, Ngo T, Jiang R, Zamecnik C . Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med. 2021; 2(5):100288. PMC: 8091032. DOI: 10.1016/j.xcrm.2021.100288. View

Apple A, Oddi A, Peluso M, Asken B, Henrich T, Kelly J . Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol. 2022; 9(2):221-226. PMC: 8862406. DOI: 10.1002/acn3.51498. View

Eden A, Grahn A, Bremell D, Aghvanyan A, Bathala P, Fuchs D . Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms. JAMA Netw Open. 2022; 5(5):e2213253. PMC: 9127556. DOI: 10.1001/jamanetworkopen.2022.13253. View